This inventor holds 1 USPTO granted patent. Top assignees: Merck & Co., Inc. & Laboratories, Merck Sharp & Dohme-Chibret. Active years: 1983.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 2 Years Active: 1983
Title: The Innovations of Jean-Claude Le Douarec
Introduction
Jean-Claude Le Douarec is a notable inventor based in Chamalieres, France. He has made significant contributions to the field of ophthalmology through his innovative inventions. His work primarily focuses on developing formulations that address eye-related health issues.
Latest Patents
Jean-Claude Le Douarec holds a patent for ophthalmic formulations that include 5-fluoro-2-methyl-1-(p-methylthiobenzylidene)-3-indenylacetic acid or ophthalmologically acceptable salts thereof. This invention aims to reduce or control inflammation of the eye, showcasing his commitment to improving ocular health.
Career Highlights
Throughout his career, Le Douarec has worked with prominent companies such as Merck & Co., Inc. and Merck Sharp & Dohme-Chibret. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in pharmaceutical formulations.
Collaborations
Some of his notable coworkers include Tsung-Ying Shen and Philippe Conquet. Their collaborative efforts have likely played a role in the development of innovative solutions in the field of ophthalmology.
Conclusion
Jean-Claude Le Douarec's contributions to ophthalmic formulations highlight his dedication to advancing eye care. His patent reflects a significant step forward in managing eye inflammation, and his collaborations with esteemed professionals further enhance his impact in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile